Company Profile
Shockwave Medical Stock Price, News & Catalysts
- Ticker:
- SWAV
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for SWAV.
Company overview
Business overview
Shockwave Medical was a medical technology company focused on intravascular lithotripsy for cardiovascular disease before being acquired by Johnson & Johnson. Its platform changed how clinicians approached calcium-related vessel treatment.
Geographic Base and Sector Classification
Shockwave was headquartered in the United States and listed on NASDAQ before the acquisition. It sat in high-growth cardiovascular medtech rather than biotech.
Business Model Characteristics
The company generated value through procedure adoption, product expansion, and the widening use of its lithotripsy platform. Investors watched procedural growth, international adoption, and system penetration.
Position Within the Biotechnology Landscape
Shockwave was outside biotech but was one of the most important procedure-driven medtech growth names. Because it has been acquired, it is now a historical reference point rather than a live public company.
Future catalysts
- Shockwave’s catalyst story is still intravascular lithotripsy adoption and how the franchise is being integrated into the broader commercial footprint. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Shockwave Medical do?
Shockwave Medical was a medical technology company focused on intravascular lithotripsy for cardiovascular disease before being acquired by Johnson & Johnson. Its platform changed how clinicians approached calcium-related vessel treatment.
On which exchange is SWAV stock listed?
Shockwave Medical (SWAV) is associated with NASDAQ, United States, Biopharma.
What is Shockwave?
Shockwave’s catalyst story is still intravascular lithotripsy adoption and how the franchise is being integrated into the broader commercial footprint.
Which conditions is Shockwave Medical targeting with Shockwave?
Shockwave Medical is associated with cardiovascular disease based on its company overview and current catalyst commentary.
How does Shockwave Medical describe recent progress with Shockwave?
Shockwave’s catalyst story is still intravascular lithotripsy adoption and how the franchise is being integrated into the broader commercial footprint.
What is Medical?
Shockwave Medical was a medical technology company focused on intravascular lithotripsy for cardiovascular disease before being acquired by Johnson & Johnson.
What should investors watch for with Medical?
Shockwave’s catalyst story is still intravascular lithotripsy adoption and how the franchise is being integrated into the broader commercial footprint. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens,...
What is Johnson?
Shockwave Medical was a medical technology company focused on intravascular lithotripsy for cardiovascular disease before being acquired by Johnson & Johnson.